COPD trials in Netherlands

In Netherlands 24 Also abroad 559

17 of 24 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Not yet taking people in Netherlands
The MAB Trial: A Study of Tozorakimab to Reduce Lung Inflammation and Promote Lung Healing in People with COPD.
Where
Groningen
Age
18 years and over
People
60 worldwide
Run by
University Of Leicester
See details and how to join2025-522359-24-00 · EU 2025-522359-24-00
Phase 3Taking people
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
Where
Leiden
Age
18 years to 80 years
People
40 worldwide
Run by
Grifols Therapeutics LLC
See details and how to joinNCT07555483 · EU 2025-522792-29-00
Phase 3Taking people
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Where
Arnhem, Breda, Dordrecht, Nijmegen, The Hague, Zutphen
Age
40 years to 80 years
People
942 worldwide
Run by
Sanofi
See details and how to joinNCT07190222 · EU 2024-518213-25-00
Phase 4Taking people
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
Where
Groningen, Hoofddorp, Nijmegen, Rotterdam
Age
40 years to 85 years
People
218 worldwide
Run by
Sanofi
See details and how to joinNCT07053423
No phaseTaking people
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Where
Groningen
Age
40 years to 84 years
People
250 worldwide
Run by
Apreo Health, Inc.
See details and how to joinNCT06891755
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Where
Eindhoven, Maastricht, Rotterdam, Zutphen
Age
40 years to 80 years
People
990 worldwide
Run by
AstraZeneca
See details and how to joinNCT06878261 · EU 2024-517457-27-00
Phase 3Taking people
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
Where
Breda, Deventer, Enschede, Haarlem, Harderwijk, Leeuwarden, Nijmegen, Zutphen, Zwolle
Age
40 years to 80 years
People
981 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06959095 · EU 2024-520418-22-00
No phaseTaking people
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Where
Groningen
Age
40 years to 80 years
People
200 worldwide
Run by
Pulmonx Corporation
See details and how to joinNCT06035120
Phase 3Taking people
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Where
Breda, Enschede, Maastricht
Age
40 years to 75 years
People
1,196 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07177339 · EU 2025-521108-23-00
Phase 4Taking people
Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels
Where
Groningen
Age
40 years and over
People
135 worldwide
Run by
Maria Joyera Rodríguez
See details and how to joinNCT06334575
No phaseTaking people
A Trial of the Implantable Artificial Bronchus 50 Flex in Patients With Severe Emphysema
Where
Groningen
Age
22 years and over
People
20 worldwide
Run by
Pulmair Medical, Inc.
See details and how to joinNCT07086339
Phase 2Taking people
Psilocybin Therapy for Psychological Distress in Palliative Patients
Where
Groningen
Age
18 years and over
People
108 worldwide
Run by
University Medical Center Groningen
See details and how to joinNCT06782724 · EU 2023-510488-36-01
No phaseTaking people
PEP-buddy in COPD: Effect on Dyspnea Severity and Mechanism of Action
Where
Groningen
Age
40 years and over
People
25
Run by
University Medical Center Groningen
See details and how to joinNCT05938738
Phase 4Taking people
Molecular signatures associated with response to ICS treatment in patients with COPD stratified by eosinophil levels
Where
Groningen
Age
18 years to 64 years
People
60 worldwide
Run by
Fundacio De Recerca Clinic Barcelona-Institut D’investigacions Biomediques August Pi I Sunyer
See details and how to join2023-505245-13-00 · EU 2023-505245-13-00
No phaseTaking people
Triple Therapy Convenience by the Use of One or Multiple Inhalers and Digital Support in Chronic Obstructive Pulmonary Disease
Where
Rotterdam
Age
40 years and over
People
300
Run by
Franciscus Gasthuis
See details and how to joinNCT05495698
No phaseTaking people
High Flow Nasal Oxygen for Exacerbation COPD
Where
Delft, Rotterdam, The Hague
Age
40 years and over
People
40
Run by
Franciscus Gasthuis
See details and how to joinNCT06084117
No phaseTaking people
The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema
Where
Groningen
Age
40 years and over
People
30 worldwide
Run by
Morair Medtech, LLC
See details and how to joinNCT06655428